Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American National Insurance Q4 Profit Rises

RELATED NEWS
Trade ANAT now with 

American National Insurance Co. (ANAT: Quote) Monday reported fourth-quarter net income of $56.14 million or $2.10 per share, compared to $35.57 million or $1.33 per share in the same period last year.

Fourth-quarter operating earnings, which exclude some investment gains, improved to $34.54 million or $1.29 per share from $20.21 million or $0.76 per share last year.

Net realized investment gains for the quarter was $21.60 million or $0.81 per share compared to $15.36 million or $0.57 per share last year.

Revenues for the quarter were $776.66 million compared to $784.89 million last year.

Click here to receive FREE breaking news email alerts for American National Insurance Co and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.